Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,425,513 papers from all fields of science
Search
Sign In
Create Free Account
etofenamate
Known as:
2-(2-hydroxyethoxy)-ethyl-N-(alpha,alpha,alpha-trifluoro- m-tolyl)anthranilate
, Benzoic acid, 2-((3-(trifluoromethyl)phenyl)amino)-, 2-(2-hydroxyethoxy)ethyl ester
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
Broader (2)
Anti-Inflammatory Agents, Non-Steroidal
Flufenamic Acid
Narrower (3)
Aspitopic
Rheuma-Gel-ratiopharm
Rheumon
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Combined contact and photocontact allergic dermatitis to etofenamate in flogoprofen gel
J. S. rez
,
Tatiana Sanz S nchez
,
Amaro Garc ez
2001
Corpus ID: 73171921
Abstract We report a case of combined contact and photocontact allergic dermatitis to etofenamate in Flogoprofen gel (Chiesi…
Expand
2001
2001
Combined contact and photocontact allergic dermatitis to etofenamate in flogoprofen gel.
Javier Sánchez-Pérez
,
Tatiana Sanz Sánchez
,
A. García-Díez
American Journal of Contact Dermatitis
2001
Corpus ID: 26071648
We report a case of combined contact and photocontact allergic dermatitis to etofenamate in Flogoprofen gel (Chiesi Wasserman…
Expand
1997
1997
Photoallergic contact dermatitis due to flufenamic acid and etofenamate
J. Montoro
,
M. Rodríguez‐Serna
,
J. Linana
,
M. A. Ferre
,
J. Sánchez-Motilla
Contact Dermatitis
1997
Corpus ID: 31899132
Chlorphcnesin ( 3-(4-chlorophenoxy)-1 ,2-propanediol) is an antimicrobial which is active against some pathogenic dermatophytes…
Expand
1994
1994
Allergic contact dermatitis from etofenamate: report of 9 cases
J. Hergueta
,
F. Ortiz
,
L. Iglesias
Contact Dermatitis
1994
Corpus ID: 9927303
All 4 urushiol-sensitive subjects showed strong positive reactions to urushiol at 0.002% pet. and PDC at 0.1% pet., and they also…
Expand
Highly Cited
1993
Highly Cited
1993
The isolated perfused bovine udder as an in vitro model of percutaneous drug absorption. Skin viability and percutaneous absorption of dexamethasone, benzoyl peroxide, and etofenamate.
Manfred Kietzmann
,
Wolfgang Löscher
,
Dorothee Arens
,
Petra Maaβ
,
Dietrich Lubach
Journal of pharmacological and toxicological…
1993
Corpus ID: 36690998
1992
1992
Contact dermatitis from etofenamate
A. Götze
,
G. Teikemeier and
,
G. Goerz
Contact Dermatitis
1992
Corpus ID: 29989198
A 53-year-old woman presented with exudative erythematous dermatitis localized to the arms and face. For rheumatic elbow pain…
Expand
1990
1990
Study on the effect of etofenamate 10% cream in comparison with an oral NSAID in strains and sprains due to sports injuries.
G. Vanderstraeten
,
P. Schuermans
Acta Belgica. Medica physica : organe officiel de…
1990
Corpus ID: 34478445
In this 60 patient study of sports traumatology due to football injuries, etofenamate gel proved equally effective as oral…
Expand
1988
1988
Etofenamate and transcutaneous electrical nerve stimulation treatment of painful spinal syndromes.
R. Coletta
,
F. Maggiolo
,
S. Di Tizio
International journal of clinical pharmacology…
1988
Corpus ID: 23137225
Thirty patients suffering from painful syndromes of the spine were admitted to a randomized controlled clinical trial. They were…
Expand
1984
1984
Contact urticaria to etofenamate
J. Piñól
,
F. Carapeto
Contact Dermatitis
1984
Corpus ID: 5314009
serious complaint concerning skin irritation from this product, sold for more than 12 years. This is not surprising, since people…
Expand
1981
1981
Contact dermatitis from an antirheumatic gel containing etofenamate
J. Vanhee
,
D. Gevers
,
A. Dooms‐goossens
Contact Dermatitis
1981
Corpus ID: 24006680
trunk and proximal part of the extremities. For a recent recurrence the patient had been treated for a week with 1…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE